Century Therapeutics, Inc. Quarterly Deferred Income Tax Liabilities, Net in USD from Q4 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
Century Therapeutics, Inc. quarterly Deferred Income Tax Liabilities, Net history and growth rate from Q4 2021 to Q2 2024.
  • Century Therapeutics, Inc. Deferred Income Tax Liabilities, Net for the quarter ending June 30, 2024 was $3.37M.
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $3.37M Jun 30, 2024 10-Q 2024-08-08
Q4 2023 $10.4M -$915K -8.1% Dec 31, 2023 10-K 2024-03-14
Q4 2022 $11.3M +$3.93M +53.3% Dec 31, 2022 10-K 2024-03-14
Q4 2021 $7.37M Dec 31, 2021 10-K 2023-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.